A compound made by cannabis plants has been found to wipe out one of the most common drug-resistant bacteria in a study on mice, raising hopes of a new weapon in the fight against superbugs.
From the complexities of regulation and cutting-edge science to the brands behind the boom, the CBD Global Summit will bridge the business and science underpinning this fast-moving category.
Holista CollTech has filed for a global patent for its water-soluble delivery system, which it claims makes fat-soluble molecules such as cannabidiol (CBD) more readily absorbed by the body.
Gencor has gained the Therapeutic Goods Administration (TGA) approval for its palmitoylethanolamide (PEA) for use as an active ingredient in listed medicines in Australia.
CBD has caught the public's imagination as an ingredient offering a host of potential health benefits. But for all the hype, CBD also courts controversy. To move from a trending ingredient to an ingredient trend, the sector will need to address some...
Successful CPG brands market a feeling, not an ingredient (especially one about to be as ubiquitous as CBD), says the founder of Recess, who is building a lifestyle brand that includes the hottest ingredient in town... but doesn’t shout about it on pack.
In this round up, we feature the current and upcoming health and nutrition trends, including supplement firms' interest in Thailand's hemp and CBD market, functional foods and supplements becoming a key contributor to Australian market by 2030...
A number of hemp and CBD product manufacturers have expressed interest in doing business in Thailand, after the country recently announced changes to its regulations.
The regulatory framework and the history of using medicinal cannabis in the APAC market have laid a strong foundation for the expansion of CBD supplements in the region, according to manufacturer Elixinol.
Bod Australia has stated that the absence of a clear pathway to market for its CBD products explains why APAC is “not yet on the radar” for its recently announced distribution deal with NewH2.
From NZMP's establishment of a sports nutrition and lifestyle unit in APAC, to Blackmores advocating sustainable ingredient sourcing, and an Australian study on the impact of diet on multiple sclerosis, read the five most popular stories on the social...
Canadian company Harvest One is eyeing entry into key East Asian markets with its sleep aid supplement, Dream Water, and hopes to eventually reach the rest of the APAC region as well with a range of CBD products.
Australia's first trial to test the effects of CBD (cannabidiol) oil on individuals suffering from post-traumatic stress disorder (PTSD) will feature Bod Australia's proprietary CBD oil, MediCabilis.
Read about Mundipharma entering Vietnam's nutraceutical space, Vitaco's Asian and Middle Eastern ambitions, technological advances in China's CBD sector, and India's newest functional beverage and nutraceutical innovations.
China firm Hanyi Bio-tech has developed a technology to increase the water-solubility of cannabidiol (CBD), and aims to expand its application into a range of health food and supplement products.
Australian bio-pharmaceutical firm MGC Pharmaceuticals is eyeing expansion in East and South East Asia with its cannabis-based nutraceutical products, after having recently launched in China.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
Medical marijuana may soon make some progress in India, but any hope of more relaxed regulations on CBD or hemp for nutraceuticals has gone up in smoke, according to one industry expert.
Get our most recent news on nutraceuticals and vitamin C in India, CBD legislation in Australia, India and the Philippines, and Promisia's continued fight against government prosecution regarding its controversial arthritis supplement.
Australian company Cann Global says it will be able to bring forward its production schedule and cut costs after signing a memorandum of understanding (MoU) with Bio Health Pharmaceuticals.
China Health Industries Holdings saw its revenue jump by 50% year-on-year during the second quarter of its FY 2019, ending December 2018, on the back of strong demand for products containing hemp.
Read the latest news on aland's sports nutrition plans, Bod Australia's booming CBD and hemp business, Nissin's shift from cup noodles to nutricosmetics, and more in this month's brand round-up.
Australian firm Bod Australia reported a record US$872,240 (A$1.22m) revenue for Q4 2018, due largely to portfolio expansion and new distribution agreements.
In this month's Japan round-up, we bring you the latest research on microalgae euglena powder for liver health, matcha's stress-reducing effects and the role of prebiotics and probiotics for healthy ageing, as well as news on the latest hemp...
BioCeuticals' heavy investment in medical cannabis research, DSM China's sustainability efforts, and Sattvaponics' agricultural innovations feature alongside news on dietary supplement and infant formula contaminant in our five most read...
Hemp oil supplements are gaining higher acceptance in Japan, with manufacturer Elixinol ramping up its investment in the country on the back of more favourable advertising rules.